Monthly Archives: July 2015

The 20 Best Stocks For Value Investors This Week – 7/25/15

We evaluated 40 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic…

Week In Review: 3SBio Acquires Wansheng Pharma For $85 Million

Deals and Financings 3SBio (HK:1530) of Shenyang acquired Zhejiang Wansheng Pharma, a small molecule drugmaker, for $85 million (see story). Wansheng is approved to market 55 products in the areas of oncology, diabetes, cardiovascular and dermatology. It also has 13 GMP production lines. The transaction is priced at 20 times Wansheng’s earnings and slightly less than…

Dollar Correction May Not Be Complete, But Fed Expectations To Li

The overextended technical condition of the dollar we highlighted previously was expressed in a mixed performance last week. Against the top ten currencies, that dollar fell against five. The drop in oil prices and other commodity prices encouraged rate cut expectations in Australia and Canada, sending those currencies to new multi-year lows.   The New Zealand…

Buy These 2 All-American Growth Stocks

As we get deeper into earnings season it is clear that a strong dollar and lagging global growth are digging into the top and bottom lines of many companies. That’s why Bret Jensen is recommending these two all-American stocks that can take advantage of our strengthening domestic economy and will not be pressured by the…

Greek Deal Is Another Dangerous Wimp-Out

The Greek deal reached in the early hours of last Monday and ratified by the Greek parliament Wednesday drew a sigh of relief from investors. Unfortunately, that reaction was not simply premature. It’s completely misguided. Greece would be far better off leaving the eurozone, and the common currency would be strengthened by its departure. Meanwhile,…

EC Measuring U

New claims for unemployment insurance this week came in at the lowest level in over 40 years. How much slack can there be left in the labor market? Initial claims for unemployment insurance, weekly, 1967-01-07 to 2015-07-18. Source: FRED. The most common measure of unemployment (known as U3) counts the number of people who are not…

Bearish Cracks Vs. “Be Patient” Facts

Last 28 Months – Fed Policy Side Effects? Observable Deterioration “Be Patient” Evidence After A Similar Consolidation Period In 1904, What Happened? After A Similar Consolidation Period In 1934, What Happened? After A Similar Consolidation Period In 1994, What Happened? Did Sentiment Set Another Skeptical Record? Weak Transportation Average – Showstopper? Weak Breadth – A…

Profit From Emerging Market Health Care Growth With Abbott Labora

Abbott Laboratories (ABT) recently released its 2nd quarter 2015 results. The company saw adjusted earnings-per-share grow 6.1% to $0.52 per share from $0.49 per share in the same quarter a year ago. Abbott Laboratories left its adjusted earnings-per-share guidance for full fiscal 2015 unchanged at $2.10 to $2.20 per share. The company had adjusted earnings-per-share from continuing operations…

A New Coordinated Fiscal-Monetary Management Proposal For India

by Ajay Shah, ajayshahblog When the Financial Sector Legislative Reforms Commission (FSLRC) produced the draft Indian Financial Code (IFC) in March 2013, the Ministry of Finance put it out for public review and comments. This version is informally termed IFC v1.0. Hundreds of comments were received on this first draft. Justice Srikrishna and his team worked on these comments…

Analysis In Real Time Is Only For Shock Value

Do you consider how inaccurate the monthly economic releases are? Every day, the markets react to the deviation from expectations for releases on employment, manufacturing, spending et al. No consideration is made to the backward revisions which effect HOW one should view the current data. Analysis of monthly movements are hardly ever correct as backward revisions,…